Use access key #2 to skip to page content.
$43.56 1.11 (2.61%)
5/16/2008 4:01 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar delocin (64.55) Submitted: 4/27/08 4:49 PM : Outperform Start Price: $42.39 AZN Score: 0.73

Two words: baby boomers. As boomers age, the drugs made by AstraZeneca will become more necessary. I expect this stock to double in the next 7-10 years. Of course, as new drugs come out and go through their trials with the FDA, or lose their patent protection, the stock will bounce around, generally going higher.

Report this Post Replies: 0 | Reply

Featured Broker Partners